Obagi CLENZIderm M.D. Systems are the only acne treatments that contain a patented, solubilized form of 5% benzoyl peroxide (BPO) to penetrate deep into the follicle with the aim of treating acne where it starts.
Available in two distinct systems, for normal to oily skin or normal to dry skin, these simple, 3-step, physician-dispensed acne therapies from Obagi Medical are clinically proven to better penetrate the follicles for effective P. acnes bacteria reduction and rapid lesion reduction.*
Who can benefit from the CLENZIderm M.D. Normal to Oily System?
Who can benefit from the CLENZIderm M.D. Normal to Dry System?
Ask your Melior Clinics skin care professional today which CLENZIderm M.D. System is right for you.
CLENZIderm M.D. Systems are clinically proven to penetrate more effectively than leading benzoyl peroxide products because of their solubilized BPO formulation. This powerful medication penetrates deep into the follicles to reduce acne where it starts; providing a visibly clearer complexion in as little as 2 weeks.
Normal to Oily – Clinical studies show that the CLENZIderm M.D. Normal to Oily System significantly reduces follicular P. acnes bacteria compared to a leading BPO/clindamycin combination. Reduction in follicular P. acnes was apparent immediately after a single application and sustained improvement through eight hours. The Normal to Oily System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions for results your patients can see and feel.
Normal to Dry – The CLENZIderm M.D. Normal to Dry System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions while minimizing dryness and maximizing patient comfort.
In a recent clinical study, the following results were reported after 2 weeks of once-daily application: